Advertisement
UK markets closed
  • FTSE 100

    7,995.58
    +71.78 (+0.91%)
     
  • FTSE 250

    19,721.24
    -65.63 (-0.33%)
     
  • AIM

    755.91
    -2.92 (-0.38%)
     
  • GBP/EUR

    1.1694
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2451
    -0.0104 (-0.83%)
     
  • Bitcoin GBP

    51,667.83
    -2,379.09 (-4.40%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,123.41
    -75.65 (-1.46%)
     
  • DOW

    37,983.24
    -475.84 (-1.24%)
     
  • CRUDE OIL

    85.45
    +0.43 (+0.51%)
     
  • GOLD FUTURES

    2,360.20
    -12.50 (-0.53%)
     
  • NIKKEI 225

    39,523.55
    +80.92 (+0.21%)
     
  • HANG SENG

    16,721.69
    -373.34 (-2.18%)
     
  • DAX

    17,930.32
    -24.16 (-0.13%)
     
  • CAC 40

    8,010.83
    -12.91 (-0.16%)
     

Best Momentum Stocks to Buy for January 25th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 25th:

Eton Pharmaceuticals, Inc. ETON: This specialty pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.6% over the last 60 days.

Eton Pharmaceuticals, Inc. Price and Consensus

Eton Pharmaceuticals, Inc. Price and Consensus
Eton Pharmaceuticals, Inc. Price and Consensus

Eton Pharmaceuticals, Inc. price-consensus-chart | Eton Pharmaceuticals, Inc. Quote

Eton’s shares gained 51.5% over the last three months compared with the S&P 500’s advance of 4.7%. The company possesses a Momentum Score of A.

Eton Pharmaceuticals, Inc. Price

Eton Pharmaceuticals, Inc. Price
Eton Pharmaceuticals, Inc. Price

Eton Pharmaceuticals, Inc. price | Eton Pharmaceuticals, Inc. Quote

ADVERTISEMENT

Okta, Inc. OKTA: This identity solutions company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 62% over the last 60 days.

Okta, Inc. Price and Consensus

Okta, Inc. Price and Consensus
Okta, Inc. Price and Consensus

Okta, Inc. price-consensus-chart | Okta, Inc. Quote

Okta’s shares gained 20.6% over the last three months compared with the S&P 500’s advance of 4.7%. The company possesses a Momentum Score of A.

Okta, Inc. Price

Okta, Inc. Price
Okta, Inc. Price

Okta, Inc. price | Okta, Inc. Quote

Vizsla Silver Corp. VZLA: This explorer and developer of precious and base metal assets has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.

Vizsla Silver Corp. Price and Consensus

Vizsla Silver Corp. Price and Consensus
Vizsla Silver Corp. Price and Consensus

Vizsla Silver Corp. price-consensus-chart | Vizsla Silver Corp. Quote

Vizsla’s shares gained 11% over the last three months compared with the S&P 500’s advance of 4.7%. The company possesses a Momentum Score of B.

Vizsla Silver Corp. Price

Vizsla Silver Corp. Price
Vizsla Silver Corp. Price

Vizsla Silver Corp. price | Vizsla Silver Corp. Quote

 

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Okta, Inc. (OKTA) : Free Stock Analysis Report

Eton Pharmaceuticals, Inc. (ETON) : Free Stock Analysis Report

Vizsla Silver Corp. (VZLA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research